AnimAb SRL
5.6 FTEThe score of AnimAb shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -56 % Total assets -48 % Headcount (avg FTE) +155 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
AnimAb's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Jun 2026
- Year ended 31 Dec 2024filed on 03 Jul 2025
- Year ended 31 Dec 2023filed on 11 Jun 2024
- Year ended 31 Dec 2022filed on 31 May 2023
- Year ended 31 Dec 2021filed on 09 Jun 2022
AnimAb's financial analysis
- Solvency79.6%sector median: 47.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of AnimAb
AnimAb's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0747.674.614
- VAT number
- BE0747674614
- Peppol
- Registered · 0208:0747674614 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 May 2020
- Registered office
- 9052 Ghent
- Size
- Micro · 5.6 FTE
- Latest accounts
- 2025 · filed on 17 Jun 2026
- Activity
- Manufacture of medicaments (NACE 21201)
AnimAb (SRL) has been based in Ghent since 2020, active in: manufacture of medicaments. For 2025, it reports a net loss of €5.30m and equity of €2.76m; its revenue is not published. With 5.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 79.6%, above the median of its sector (47.2%).
Companies similar to AnimAb
Companies in the same business, of comparable size and area, outside its group.
- ExoXpert Manufacture of pharmaceutical preparations Liège · balance sheet €2.05m
- Xedev Other information service activities Zele · balance sheet €2.72m
- Temmune Therapeutics Manufacture of pharmaceutical preparations Mechelen · balance sheet €3.43m
- Orotech Manufacture of pharmaceutical preparations Temse · balance sheet €1.21m
- Boehringer Ingelheim Veterinary Medicine Belgium NV Research and experimental development on natural sciences and engineering Evergem · balance sheet €6.51m
- Plant Bio Technologies Manufacture of basic pharmaceutical products Ghent · balance sheet €1.04m
- invoX Belgium Manufacture of pharmaceutical preparations Diepenbeek · balance sheet €29.2m
- DeuterOncology Manufacture of basic pharmaceutical products Liège · balance sheet 688,028 €
Frequently asked questions about AnimAb
What is the revenue of AnimAb?
AnimAb files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of AnimAb?
In Belgium, the VAT number is the company number prefixed with BE: BE0747674614 for AnimAb, if the company is VAT-registered. Its company number (CBE) is 0747.674.614.
Where is the registered office of AnimAb?
According to the CBE register, the registered office of AnimAb is in 9052 Ghent.
What is the equity of AnimAb?
At the close of the 2025 financial year, the equity of AnimAb amounts to 2,759,876 €, a solvency of 79.6% of total assets.
How many people work at AnimAb?
5.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages AnimAb?
The register lists 13 active mandates at AnimAb. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of AnimAb
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →